@inproceedings{ca871d90282c49428705d6558c1ac478,
title = "An open-label study adding creatine monohydrate to ongoing medical regimens in patients with the fibromyalgia syndrome",
abstract = "Fibromyalgia is an ill-defined condition that causes pain and disability but still lacks effective treatment. The aim of this open-label study was to assess the efficacy of administering a food supplement, creatine monohydrate, in an {"}add on{"} to existing therapies in patients with fibromyalgia. This study included 30 patients with fibromyalgia. After 8 weeks of receiving creatine, we witnessed a significant improvement in parameters reflecting severity of fibromyalgia, quality of life and sleep, disability, and pain. These results deteriorated 4 weeks after stopping creatine therapy. The findings of this study are preliminary and limited due to the small sample and relatively high rate of dropouts.",
keywords = "Anxiety, Depression, Fibromyalgia, Pain, Quality of life",
author = "Avi Leader and Daniella Amital and Alan Rubinow and Howard Amital",
year = "2009",
month = sep,
doi = "10.1111/j.1749-6632.2009.04811.x",
language = "אנגלית",
isbn = "9781573317627",
series = "Annals of the New York Academy of Sciences",
publisher = "Blackwell Publishing Inc.",
pages = "829--836",
booktitle = "Contemporary Challenges in Autoimmunity",
}